Antibiotic combination indications for the treatment of community-acquired acute pneumonia
Open Access
- 30 July 2025
- journal article
- review article
- Published by Elsevier in Infectious Diseases Now
- Vol. 55 (6) , 105126
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Update of guidelines for management of community acquired pneumonia in adults by the French infectious disease society (SPILF) and the French-speaking society of respiratory diseases (SPLF). Endorsed by the French intensive care society (SRLF), the French microbiology society (SFM), the French radiology society (SFR) and the French emergency society (SFMU)Infectious Diseases Now, 2025
- The Dutch Working Party on Antibiotic Policy (SWAB) guideline for the approach to suspected antibiotic allergyClinical Microbiology and Infection, 2023
- Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trialThe Lancet, 2021
- Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired PneumoniaChest, 2019
- Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumoniaRespiratory Medicine, 2018
- Effectiveness of combination therapy versus monotherapy with a third-generation cephalosporin in bacteraemic pneumococcal pneumonia: A propensity score analysisJournal of Infection, 2018
- β-Lactam Monotherapy vs β-Lactam–Macrolide Combination Treatment in Moderately Severe Community-Acquired PneumoniaJAMA Internal Medicine, 2014
- Association of Azithromycin With Mortality and Cardiovascular Events Among Older Patients Hospitalized With PneumoniaJAMA, 2014
- The clinical efficacy of fluoroquinolone and macrolide combination therapy compared with single-agent therapy against community-acquired pneumonia caused by Legionella PneumophilaJournal of Infection, 2009
- Impact of rifampicin addition to clarithromycin in Legionella pneumophila pneumoniaInternational Journal of Antimicrobial Agents, 2006